228 related articles for article (PubMed ID: 30638292)
21. Citrullination mediated by PPAD constrains biofilm formation in P. gingivalis strain 381.
Vermilyea DM; Ottenberg GK; Davey ME
NPJ Biofilms Microbiomes; 2019 Feb; 5(1):7. PubMed ID: 32029738
[TBL] [Abstract][Full Text] [Related]
22.
Prucsi Z; Zimny A; Płonczyńska A; Zubrzycka N; Potempa J; Sochalska M
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629104
[TBL] [Abstract][Full Text] [Related]
23. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.
Wegner N; Wait R; Sroka A; Eick S; Nguyen KA; Lundberg K; Kinloch A; Culshaw S; Potempa J; Venables PJ
Arthritis Rheum; 2010 Sep; 62(9):2662-72. PubMed ID: 20506214
[TBL] [Abstract][Full Text] [Related]
24. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
25. Citrullination in the periodontium--a possible link between periodontitis and rheumatoid arthritis.
Laugisch O; Wong A; Sroka A; Kantyka T; Koziel J; Neuhaus K; Sculean A; Venables PJ; Potempa J; Möller B; Eick S
Clin Oral Investig; 2016 May; 20(4):675-83. PubMed ID: 26264638
[TBL] [Abstract][Full Text] [Related]
26. Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.
Abdullah SN; Farmer EA; Spargo L; Logan R; Gully N
Anaerobe; 2013 Oct; 23():102-8. PubMed ID: 23856045
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of epidermal growth factor by Porphyromonas gingivalis as a potential mechanism for periodontal tissue damage.
Pyrc K; Milewska A; Kantyka T; Sroka A; Maresz K; Kozieł J; Nguyen KA; Enghild JJ; Knudsen AD; Potempa J
Infect Immun; 2013 Jan; 81(1):55-64. PubMed ID: 23090954
[TBL] [Abstract][Full Text] [Related]
28. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD).
Maresz KJ; Hellvard A; Sroka A; Adamowicz K; Bielecka E; Koziel J; Gawron K; Mizgalska D; Marcinska KA; Benedyk M; Pyrc K; Quirke AM; Jonsson R; Alzabin S; Venables PJ; Nguyen KA; Mydel P; Potempa J
PLoS Pathog; 2013 Sep; 9(9):e1003627. PubMed ID: 24068934
[TBL] [Abstract][Full Text] [Related]
29. Impact of Porphyromonas gingivalis Peptidylarginine Deiminase on Bacterial Biofilm Formation, Epithelial Cell Invasion, and Epithelial Cell Transcriptional Landscape.
Aliko A; Kamińska M; Bergum B; Gawron K; Benedyk M; Lamont RJ; Malicki S; Delaleu N; Potempa J; Mydel P
Sci Rep; 2018 Sep; 8(1):14144. PubMed ID: 30237466
[TBL] [Abstract][Full Text] [Related]
30. Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis.
Engström M; Eriksson K; Lee L; Hermansson M; Johansson A; Nicholas AP; Gerasimcik N; Lundberg K; Klareskog L; Catrina AI; Yucel-Lindberg T
J Transl Med; 2018 Jul; 16(1):214. PubMed ID: 30064459
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of
Tan SA; Yam HC; Cheong SL; Chow YC; Bok CY; Ho JM; Lee PY; Gunasekaran B
Saudi J Biol Sci; 2022 Apr; 29(4):2573-2581. PubMed ID: 35531186
[No Abstract] [Full Text] [Related]
32. The activity of bacterial peptidylarginine deiminase is important during formation of dual-species biofilm by periodontal pathogen Porphyromonas gingivalis and opportunistic fungus Candida albicans.
Karkowska-Kuleta J; Bartnicka D; Zawrotniak M; Zielinska G; Kieronska A; Bochenska O; Ciaston I; Koziel J; Potempa J; Baster Z; Rajfur Z; Rapala-Kozik M
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29668945
[TBL] [Abstract][Full Text] [Related]
33. TLR2 Activation by
Wielento A; Bereta GP; Łagosz-Ćwik KB; Eick S; Lamont RJ; Grabiec AM; Potempa J
Front Immunol; 2022; 13():823685. PubMed ID: 35432342
[No Abstract] [Full Text] [Related]
34. Accessory fimbrial subunits and PPAD are necessary for TLR2 activation by Porphyromonas gingivalis.
Wielento A; Bereta GP; Szczęśniak K; Jacuła A; Terekhova M; Artyomov MN; Hasegawa Y; Grabiec AM; Potempa J
Mol Oral Microbiol; 2023 Aug; 38(4):334-346. PubMed ID: 37347653
[TBL] [Abstract][Full Text] [Related]
35. Theoretical insights into the protonation states of active site cysteine and citrullination mechanism of Porphyromonas gingivalis peptidylarginine deiminase.
Zhao C; Ling B; Dong L; Liu Y
Proteins; 2017 Aug; 85(8):1518-1528. PubMed ID: 28486790
[TBL] [Abstract][Full Text] [Related]
36. The association between rheumatoid arthritis and periodontitis.
Leech MT; Bartold PM
Best Pract Res Clin Rheumatol; 2015 Apr; 29(2):189-201. PubMed ID: 26362738
[TBL] [Abstract][Full Text] [Related]
37. Presence of anti-Porphyromonas gingivalis-peptidylarginine deiminase antibodies in serum from juvenile systemic lupus erythematosus patients.
Figueredo CM; Sete MR; Carlos JC; Lira R; Boström E; Sztajnbok F
Acta Reumatol Port; 2018; 43(3):239-240. PubMed ID: 30414375
[TBL] [Abstract][Full Text] [Related]
38. The
Muñoz-Atienza E; Flak MB; Sirr J; Paramonov NA; Aduse-Opoku J; Pitzalis C; Curtis MA
J Dent Res; 2020 Apr; 99(4):456-462. PubMed ID: 31905316
[TBL] [Abstract][Full Text] [Related]
39. Citrullinome of
Larsen DN; Mikkelsen CE; Kierkegaard M; Bereta GP; Nowakowska Z; Kaczmarek JZ; Potempa J; Højrup P
Mol Cell Proteomics; 2020 Jan; 19(1):167-180. PubMed ID: 31754044
[No Abstract] [Full Text] [Related]
40. Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study.
Fisher BA; Cartwright AJ; Quirke AM; de Pablo P; Romaguera D; Panico S; Mattiello A; Gavrila D; Navarro C; Sacerdote C; Vineis P; Tumino R; Lappin DF; Apatzidou D; Culshaw S; Potempa J; Michaud DS; Riboli E; Venables PJ
BMC Musculoskelet Disord; 2015 Nov; 16():331. PubMed ID: 26537917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]